Company intelligence

CRBU

Caribou Biosciences, Inc. · NASDAQ · Healthcare

Price$0.54-0.11% · −$0.00

Market cap58.3MEquity value

P / E-0.5Trailing ratio

Volume2.05MLatest session

Market data

CRBU price chart

TradingView

Related signals

1 min delayed

Browse public CRBU signals with their source context and measured market impact. Open any signal for its permanent analysis page.

CRBUNov 3, 2025-15.07% since signal

Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today>

CRBU stock surged 17.56% after positive trial results. 64% of patients had complete response from CAR-T therapy. Overall response rate in the trial was 82%. FDA recommended a pivotal phase 3 trial for vispa-cel. CB-011 shows promising results for multiple myeloma treatments.

View signal analysis

Research